✦ LIBER ✦

A revolution in HCV treatment with direct-acting antivirals: From non-response to eradication

✍ Scribed by Tarik Asselah

Book ID: 116652756
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 287 KB
Volume: 57
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2012.03.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Chronic Hepatitis C in the

Treatment of Chronic Hepatitis C in the Age of Direct-Acting Antivirals with Emphasis on First Generation Inhibitors of HCV NS3/4A Protease

✍ Aimee E. Truesdale; Gregory T. Everson 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 657 KB

926 LONG TERM EFFICACY OF ANTIVIRAL THER

926 LONG TERM EFFICACY OF ANTIVIRAL THERAPY IN CHRONIC HEPATITIS C PATIENTS WITH SUSTAINED VIROLOGICAL RESPONSE TO TREATMENT WITH INTERFERON/RIBAVIRIN WITH OR WITHOUT DIRECT ACTING ANTIVIRALS

✍ K. Rutter; S. Beinhardt; P. Ferenci; P. Rauch; S. Ibrahim; M. Dulic; M. Gschwant 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Hepatitis C Virus Variants with Decrease

Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment

✍ Bartels, D. J.; Sullivan, J. C.; Zhang, E. Z.; Tigges, A. M.; Dorrian, J. L.; De 📂 Article 📅 2012 🏛 American Society for Microbiology 🌐 English ⚖ 284 KB

Extending antiviral treatment for 12 mon

Extending antiviral treatment for 12 months after HCV-RNA clearance is associated with a high response rate in difficult-to-treat HCV patients

✍ A. Riili; C. Cursaro; A. Gramenzi; M. Salerno; F. Felline; A. Scuteri; R. Vukoti 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Minimal Important Difference (MID) of Re

Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)

✍ Baran, R.W.; Anderson, R.T.; Dietz, B.; Gooch, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

P783 SERUM miR-122 MAY SERVE AS A BIOMAR

P783 SERUM miR-122 MAY SERVE AS A BIOMARKER FOR RESPONSE TO DIRECT ACTING ANTIVIRALS: EFFECT OF ABT-450/r WITH ABT-333 OR ABT-267 ON miR-122 IN HCV-INFECTED SUBJECTS

✍ Waring, J.F.; Dumas, E.; Coakley, E.; Cohen, D.; Podsadecki, T.; Dutta, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 63 KB